Novel "rendez-vous" technique for persistent gastrocutaneous fistula closure
Abstract
Background and study aims: Gastrocutaneous (GC) fistulas are a rare but challenging adverse event that can occur after removal of a PEG tube 1 . Modern endoscopic techniques such as over-the-scope (OTS) clipping have become popular alternatives over traditional surgical closure for resolving this issue 2 . However, some fistulas fail to close despite endoscopic interventions and would normally require open surgery. Here, we devised a new "rendezvous" method, involving a combination of endoscopic and surgical approaches, to close recalcitrant fistulas.
Patients and methods: Four patients with persistent GC fistulas after long-term percutaneous endoscopic gastrostomy (PEG) use were treated with the "rendezvous" technique. This technique utilizes both endoscopic OTS clipping and extraperitoneal surgical excision of the fistula tract to avoid risks of surgery while ensuring fistula closure.
Results: The success rates was 100% with no immediate adverse events (AEs) and no recurrences within 2 years of closure in a case series of four patients with persistent GC fistulas. Three of these patients suffered from neurological disorders (cerebral palsy and Parkinson's disease) and required long-term PEG tubes. One patient required long-term PEG feeding following postoperative AE.
Conclusions: The novel "rendezvous" technique has showed success in closure of persistent GC fistulas in comorbid patients with long-term PEG use. It is a less-invasive alternative to traditional surgery and…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.